Results 91 to 100 of about 53,648 (262)
Corneal transplantation: Restoring sight to the blind
Acta Ophthalmologica, EarlyView.Abstract Corneal blindness is one of the leading causes of vision loss worldwide. Transplantation of the cornea can restore vision and make blind patients see again. Corneal transplant surgery has undergone major evolution in recent decades with the advent of minimally invasive lamellar surgical approaches such as DMEK and DALK.
Claus Cursiefen
wiley +1 more source
Primary treatment of diabetic macular edema
, 2009 Tushar M Ranchod, Stuart L FineScheie Eye Institute, Department, of Ophthalmology, University of Pennsylvania, Philadelphia, PA, USAAbstract: Diabetic macular edema (DME) is a leading cause of vision loss in older Americans.
Stuart L Fine, Tushar M Ranchod
core
Acta Ophthalmologica, EarlyView.Abstract Purpose To evaluate real‐world safety experience with aflibercept 8 mg in a large case series of patients with neovascular age‐related macular degeneration (nAMD). Methods Due to a high proportion of patients on short treatment intervals, patients with nAMD at a Danish tertiary retina clinic were systematically switched to aflibercept 8 mg ...
Mary Graciya Karunainathan +12 more
wiley +1 more source
Our first experience with subtreshold diode laser in the treatment of macular edema
Zdravniški Vestnik, 2012 Authors describe their first experience with the treatment of macular edema of different etiology with subtreshold diode micropulse laser (577 nm), which does not cause any damage to the retinal pigment epithelium.
Davorin Sevšek +2 more
doaj
Acute macular edema following intracorporeal prostaglandin injection for erectile dysfunction
, 2015 Masumi G Asahi, Calvin Chou, Ron P Gallemore Retina Macula Institute, Torrance, CA, USA Purpose: We aimed to describe the first case of macular edema following intracorporeal injection of alprostadil, a prostaglandin E1.
Asahi MG, Chou C, Gallemore RP
core
Acta Ophthalmologica, EarlyView.Abstract Purpose To estimate the real‐world incidence of intraocular inflammation (IOI) following intravitreal faricimab injections at a large, highly specialized tertiary centre. Methods Single‐centre, retrospective cohort study with chart review using an electronic injection database and electronic medical records from November 2023 to August 2024 ...
Miklos Schneider +7 more
wiley +1 more source
Revista Habanera de Ciencias Médicas, 2018 Introducción: El edema macular es la causa más frecuente de deterioro visual en pacientes con retinopatía diabética no proliferativa, la separación de los fotorreceptores, inducida por permeabilidad vascular anormal, reduce el poder de resolución del ojo
Raisa ivis Beltran Sainz +3 more
doaj
Microcystic macular edema: clinical significance and pathogenetic mechanisms
Клиническая практикаMicrocystic macular edema represents a specific type of intraretinal cystic changes, localizing predominantly in the inner nuclear layer and detectable using the optical coherence tomography.
Elizaveta A. Danilova +13 more
doaj +1 more source
Update in treatment of uveitic macular edema
, 2019 Spyridon Koronis,1 Panagiotis Stavrakas,2 Miltiadis Balidis,1 Nikolaos Kozeis,1 Paris G Tranos1 1Ophthalmica Eye Institute, Thessaloniki, Greece; 2Department of Ophthalmology, Attikon University Hospital, Athens, Greece Abstract: Macular edema (ME ...
Koronis S +4 more
core
When is macular edema not macular edema? An update on macular telangiectasia type 2
Taiwan Journal of Ophthalmology, 2015 Macular telangiectasia type 2 (Mac Tel 2) also known as idiopathic perifoveal telangiectasia and juxtafoveolar retinal telangiectasis type 2A is an enigmatic disease of unknown etiology. It manifests both neurodegenerative and vasculopathic characteristics. It manifests itself during the fifth or sixth decades of life.
openaire +2 more sources